Abstract
Mesothelioma is a deadly disease with limited treatment options. Identification and clinical characterization of biomarkers that reliably classify patients into prognostic groups may facilitate the development of novel therapeutic options for this disease. We therefore studied the expression pattern of mesothelin (MSLN), folate receptor alpha (FRA) and endosialin (TEM-1) in patients with mesothelioma.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
